AD
RACGP
RACGPRACGP CPD approved
Educational Activities
0.5 hrs
Reviewing Performance
0.5 hrs

Dr Prue Gregory, and Dr Aron Chakera

Semaglutide approved for diabetic chronic kidney disease

Semaglutide has been approved as an adjunct to care for declining kidney function and to reduce cardiovascular death in adults with type 2 diabetes.

Semaglutide approved for diabetic chronic kidney disease

Subscribers only

Log in or create a free account to access the full article.

AD